Changes/additions to materials (29th April 2010):

Since these materials were published, NICE has published new guidance which aims to reduce the risk of venous thromboembolism (VTE) in patients admitted to hospital, including day case patients. This replaces its previous guidance relating to surgical patients (CG46, April 2007). See NPCi blog for details.

NICE also published a technology appraisal on rivaroxaban▼ for the prevention of venous thromboembolism (VTE) after hip and knee surgery. It recommends oral rivaroxaban▼ (Xarelto®) as an option for the prevention of VTE in adults having elective total hip replacement surgery or elective total knee replacement surgery. Please see our blog for a brief summary of the guidance.

Test your knowledge (or just have some fun) by answering the questions in this quiz. Suggested answers are given after each question with some additional information and references. You even get a score at the end that you can print out and put in your CPD folder!

To reveal the answer to the quiz questions click on the arrow button at the bottom. The answer will then appear, however, you may need to use the slider on the right hand side of the page to reveal the whole text.

Last updated: January 2010